Translational -omics: Future potential and current challenges in precision medicine.

Rapid advances in computational science and biotechnology are paving the way for precision medicine - a vision in next-generation healthcare that promises to provide a care package uniquely tailored to each individual's molecular make-up. Until relatively recently, the focus has been firmly centred around the genome; however, over the past two decades there has been a surge in the study of molecular activity within other biological domains (proteome/transcriptome/metabolome) involved in health and pathogenesis. The term '-omics' is broadly applied to these disciplines and 'translational -omics' refers to clinical utilisation of data derived from these scientific approaches. Translational -omics represents the cornerstone of the precision medicine initiative and offers positively disruptive solutions in global healthcare from a humanitarian, scientific and economic standpoint. However, there are unique challenges anticipated for all stakeholders within the precision medicine community, and addressing these early on in the adoption of precision approaches is critical. Herein, we outline the potential for translational -omics in precision medicine, highlight key roadblocks to successful implementation and propose potential solutions to current and expected problems.